RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2

References

• HoJHAn epidemiologic and clinical study of nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys197843–4182198640889
   PubMed Web of Science ®Google Scholar
• ChenZTLiangZGZhuXDA review: proteomics in nasopharyngeal carcinomaInt J Mol Sci2015167154971553026184160
   PubMed Web of Science ®Google Scholar
• HuangLLiaoLWanYDownregulation of annexin A1 is correlated with radioresistance in nasopharyngeal carcinomaOncol Lett20161265229523428101240
   PubMed Web of Science ®Google Scholar
• ZhangLSuBSunWTwist1 promotes radioresistance in nasopharyngeal carcinomaOncotarget2016749813328134027793033
   PubMedGoogle Scholar
• QuSLiXYLiangZGProtein expression of nucleophosmin, annexin A3 and nm23-H1 correlates with human nasopharyngeal carcinoma radioresistance in vivoOncol Lett201612161562027347189
   PubMed Web of Science ®Google Scholar
• WalshJCLebedevAAtenEMadsenKMarcianoLKolbHCThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesAntioxid Redox Signal201421101516155424512032
   PubMed Web of Science ®Google Scholar
• SimkoVTakacovaMDebreovaMDexamethasone downregulates expression of carbonic anhydrase IX via HIF-1alpha and NF-kappaB-dependent mechanismsInt J Oncol20164941277128827431580
   PubMed Web of Science ®Google Scholar
• GrayLHCongerADEbertMBThe concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapyBr J Radiol195426312638648
   Google Scholar
• BrownJMTumor hypoxia in cancer therapyMethods Enzymol200743529732117998060
   PubMed Web of Science ®Google Scholar
• GatenbyRASmallboneKMainiPKCellular adaptations to hypoxia and acidosis during somatic evolution of breast cancerBr J Cancer200797564665317687336
   PubMed Web of Science ®Google Scholar
• VaupelPTumor microenvironmental physiology and its implications for radiation oncologySemin Radiat Oncol200414319820615254862
   PubMed Web of Science ®Google Scholar
• QuennetVYarominaAZipsDTumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude miceRadiother Oncol200681213013516973228
   PubMed Web of Science ®Google Scholar
• RobertsonNPotterCHarrisALRole of carbonic anhydrase IX in human tumor cell growth, survival, and invasionCancer Res200464176160616515342400
   PubMed Web of Science ®Google Scholar
• SwietachPVaughan-JonesRDHarrisALRegulation of tumor pH and the role of carbonic anhydrase 9Cancer Metastasis Rev200726229931017415526
   PubMed Web of Science ®Google Scholar
• AmbrosioMRDi SerioCDanzaGCarbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancerDiagnostic Pathol201611145
   PubMedGoogle Scholar
• LouYMcDonaldPCOloumiATargeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitorsCancer Res20117193364337621415165
   PubMed Web of Science ®Google Scholar
• ChuCYJinYTZhangWCA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancerInt J Oncol201648127128026648580
   PubMedGoogle Scholar
• SchweigerTKollmannDNikolowskyCCarbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smokingEur J Cardio-Thoracic Surg20144619299
   PubMedGoogle Scholar
• KangHJKimIHSungCOShimJHYuEExpression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinomaVirchows Arch2015466440341325577552
   PubMedGoogle Scholar
• Perez-SayansMSuarez-PenarandaJMPilarGDExpression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patientsJ Oral Pathol Med201241966767422486898
   PubMedGoogle Scholar
• KlatteTSeligsonDBRaoJYCarbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular markerCancer200911571448145819195047
   PubMedGoogle Scholar
• ChenYLiXWuSExpression of HIF-1alpha and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosisMed Oncol2014311230425377659
   PubMedGoogle Scholar
• EriksenJGOvergaardJDanishHNeck Cancer StudyGLack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 studyRadiother Oncol200783338338817543403
   PubMedGoogle Scholar
• DuivenvoordenWCHopmansSNGallinoDInhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiationOncol Rep20153441968197626252502
   PubMedGoogle Scholar
• DoyenJParksSKMarcieSPouyssegurJChicheJKnockdown of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosisFront Oncol2012219923316475
   PubMedGoogle Scholar
• BacheMMunchCGuttlerABetulinyl sulfamates as anticancer agents and radiosensitizers in human breast cancer cellsInt J Mol Sci20151611262492626226540049
   PubMedGoogle Scholar
• LuftigMHeavy lifting: tumor promotion and radioresistance in NPCJ Clin Invest2013123124999500124270417
   PubMedGoogle Scholar
• WadaSKurahayashiHKobayashiYThe relationship between cellular radiosensitivity and radiation-induced DNA damage measured by the comet assayJ Vet Med Sci200365447147712736429
   PubMedGoogle Scholar
• SangYWangLTangJJOncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinomaInt J Clin Exp Pathol2014762942294925031713
   PubMedGoogle Scholar
• KoukourakisMIBentzenSMGiatromanolakiAEndogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trialJ Clin Oncol200624572773516418497
   PubMedGoogle Scholar
• WangQWangYDuLshRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivoInt J Mol Sci20141522157217124481064
   PubMedGoogle Scholar
• HwangHSDavisTWHoughtonJAKinsellaTJRadiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitizationCancer Res20006019210010646859
   PubMedGoogle Scholar
• PawlikTMKeyomarsiKRole of cell cycle in mediating sensitivity to radiotherapyInt J Radiat Oncol Biol Phys200459492894215234026
   PubMed Web of Science ®Google Scholar
• GuoYSunWGongTmiR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATMOncol Rep20173741980198828259977
   PubMedGoogle Scholar
• ChenYLiZDongZ14-3-3sigma contributes to radioresistance by regulating DNA repair and cell cycle via PARP1 and CHK2Mol Cancer Res201715441842828087741
   PubMedGoogle Scholar
• CuiFHouJHuangCC-Myc regulates radiation-induced G2/M cell cycle arrest and cell death in human cervical cancer cellsJ Obstet Gynaecol Res201743472973528150398
   PubMed Web of Science ®Google Scholar
• FingertHJChangJDPardeeABCytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agentsCancer Res1986465246324673084068
   PubMedGoogle Scholar
• NagasawaHKengPHarleyRRelationship between gamma-ray-induced G2/M delay and cellular radiosensitivityInt J Radiat Biol19946643737930839
   PubMed Web of Science ®Google Scholar
• WangXLiQJinHmiR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancerOncotarget2016747775087751527769049
   PubMedGoogle Scholar
• JiangXZhangQLTianYHHuangJCMaGLRNA interference-mediated gene silencing of cyclophilin A enhances the radiosensitivity of PAa human lung adenocarcinoma cells in vitroOncol Lett20171331619162428454299
   PubMedGoogle Scholar
• WangJWangYMeiHThe BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21Cancer Lett201739114115128143717
   PubMedGoogle Scholar